Leading biopharmaceutical company that focuses on the development and research of specialized proprietary drugs used across the world.
If you're bullish on Flex Pharma, then I would look for long-biased trades as long as this stock is trending above some near-term support at $10.06 or even above its 20-day moving average of $9.42 a share and then once it breaks out above some near-term overhead resistance at $11.50 a share with high volume. Look for a sustained move or close above that level with...
Berkshire Partners made two significant buys. Earlier in the week, the company bought 205,409 shares of the stock at prices that fell between $39.02 and $39.48 apiece. The total for that trade came to $8 million. Later in the week, the company bought an additional 234,416 shares at share prices from $41.50 to $42.48, which cost an additional $10 million. The stock...
The investors purchased a total of 643,300 shares at prices that ranged from $2.47 to $2.50. The total for the trade came to $1.5 million. The company designs, engineers, produces and sells various cab-related products and systems in North America, Europe and the Asia/Pacific regions Read more: Insider Buying at Nimble Storage, Mattress Firm and Others (NASDAQ:...
Channel upwards Patriot National to Launch Insurance Industry's First Competitive Risk Management Online Marketplace
Massive volume of insider buying in March. To begin with, Director Donald J. Listwin purchased 100,000 shares on Thursday at $0.52 apiece, all of which are held by the Don Listwin Trust that currently owns nearly 2.34 million shares. Mr. Listwin purchased an additional 286,000 shares in mid-March. More importantly, Chief Executive Officer and President Kevin...
Leading biopharmaceutical company that focuses on the development and research of specialized proprietary drugs used across the world. Zacks Rank: #1 PEG Ratio: 0.44 Market Capitalization: $457.21 million